99 related articles for article (PubMed ID: 12899800)
1. [Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway].
Zhang Y; Sun LG; Shang H; Gao H; Yu HY; Gao SM; Liu N
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):976-80. PubMed ID: 12899800
[TBL] [Abstract][Full Text] [Related]
2. [Expression of aFGF and bFGF in ovarian cancer and their effect on ovarian cancer cell proliferation].
Zhang Y; Shang H; Sun LG; Liu N; Yu HY
Ai Zheng; 2003 Nov; 22(11):1162-5. PubMed ID: 14613644
[TBL] [Abstract][Full Text] [Related]
3. Expression of aFGF, bFGF, and FGFR1 in ovarian epithelial neoplasm.
Zhang Y; Guo KJ; Shang H; Wang YJ; Sun LG
Chin Med J (Engl); 2004 Apr; 117(4):601-3. PubMed ID: 15109457
[No Abstract] [Full Text] [Related]
4. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
Cao C; Li SR; Dai X; Chen YQ; Feng Z; Qin X; Zhao Y; Wu J
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):118-21. PubMed ID: 18785412
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
Hrzenjak M; Shain SA
Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690
[TBL] [Abstract][Full Text] [Related]
6. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
Sheng L; Liu DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
[TBL] [Abstract][Full Text] [Related]
10. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biology of pancreatic cancer: overexpression of fibroblast growth factors].
Friess H; Korc M; Büchler MW
Chirurg; 1994 Jul; 65(7):604-10. PubMed ID: 7523040
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
15. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
16. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
18. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
Yamanaka Y; Friess H; Buchler M; Beger HG; Uchida E; Onda M; Kobrin MS; Korc M
Cancer Res; 1993 Nov; 53(21):5289-96. PubMed ID: 7693336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
